Eris Lifesciences Limited
Term Loan Agreement with Axis Bank
Main Body
Eris Lifesciences Limited has entered into a term loan agreement with Axis Bank Limited. The key terms of the agreement are:
- Financial Details: The company has drawn down a term loan amounting to ₹45,00,00,000 (Rupees Forty Five Crores Only).
- Date of Execution: The loan agreement was executed on 09 September 2026.
- Parties Involved: The agreement is between Eris Lifesciences Limited (the Company) and Axis Bank Limited (the Bank).
- Purpose: The loan has been availed to meet other liabilities.
- Security: The Bank will have a charge on the brands of the Company.
- Existing Debt: The disclosure also notes the company's existing term loan outstanding is ₹155.77 Crores and its working capital loan outstanding is ₹55 Crores.
- Impact: The company states that this is a matter of routine financial adjustment and it will not impact the expected Net Debt figure at the end of the quarter.
- Related Party Status: Axis Bank Limited is not a related party to the promoter/promoter group/group companies, and the transaction is not a related party transaction.
The disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Other Key Announcements
There are no other material announcements disclosed in this filing.